Analysis

Coca-Cola (KO) looks poised to end fiscal 2024 on a mixed note

The Coca-Cola Company (NYSE: KO) has an impressive track record of effectively navigating market headwinds by continually innovating its product portfolio to

Take-Two (TTWO) expects strength in NBA 2K and softness in mobile to continue in 4Q25

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) soared 14% on Friday. The company delivered mixed results for the third quarter of

Philip Morris (PM) delivers strong performance in 4Q24 helped by smoke-free strength

Shares of Philip Morris International Inc. (NYSE: PM) jumped 10% on Thursday after the company delivered better-than-expected earnings results for the fourth

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Coca-Cola (KO) looks poised to end fiscal 2024 on a mixed note

The Coca-Cola Company (NYSE: KO) has an impressive track record of effectively navigating market headwinds by continually innovating its product portfolio to align with customers' changing consumption patterns. While the

February 7, 2025

Take-Two (TTWO) expects strength in NBA 2K and softness in mobile to continue in 4Q25

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) soared 14% on Friday. The company delivered mixed results for the third quarter of 2025, as revenue came below estimates while loss

February 7, 2025

EXPE Earnings: Expedia reports higher revenue and profit for Q4 2024

Expedia Group, Inc. (NASDAQ: EXPE) has reported a double-digit growth in revenues and adjusted earnings for the fourth quarter of 2024. The travel company's gross bookings rose 13% during the

February 7, 2025

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top